Abuse resistant oxycodone immediate release - Inspirion Delivery Sciences

Drug Profile

Abuse resistant oxycodone immediate release - Inspirion Delivery Sciences

Alternative Names: Oxycodone hydrochloride tablets; RoxyBond

Latest Information Update: 07 Jun 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inspirion Delivery Sciences
  • Class Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Registered Pain
  • Clinical Phase Unknown Drug abuse

Most Recent Events

  • 30 May 2017 RoxyBond™ licensed to Daiichi Sankyo in USA for commercialisation
  • 30 May 2017 The label for RoxyBond™ has a boxed warning
  • 16 May 2017 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top